LicianPro

Quince Therapeutics, Inc. ·

QNCX 8-K 2026-10-02

Quince Therapeutics, Inc. (QNCX) 8-K dated 2026-10-02 — accession 0001193125-26-411260.

Quince Therapeutics, Inc. (QNCX) is a biotechnology company listed on US.

Quince Therapeutics, Inc. filed a 8-K on 2026-10-02. Accession 0001193125-26-411260.

This 8-K covers: Director/officer change (Item 5.02). SEC EDGAR holds the official filing and its exhibits.

Income-statement cache for QNCX is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The QNCX SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr